Investigational Drugs

Vistagen Hit With Securities Class Actions After Phase 3 Miss as Investors Face March 16 Deadline

Plaintiff firms are recruiting shareholders for lead-plaintiff motions in a Northern District of California case following a steep post-announcement stock drop.